Association of circulating metabolites with risk of coronary heart disease in a European population: Results from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium
JAMA Nov 11, 2019
Cavus E, Karakas M, Ojeda FM, et al. - Researchers sought for the circulating metabolites that are associated with incident coronary heart disease, and investigated their predictive value for the incidence of coronary heart disease in a large European cohort. In this population-based study, the BiomarCaRE case-cohort was used. The case-cohort comprised a weighted, random subcohort of an original cohort of more than 70,000 individuals. They analyzed a total of 141 metabolites. Findings revealed a significant association of 5 phosphatidylcholines (PCs)—acyl-alkyl-PC C40:6 (hazard ratio [HR], 1.13 [95% CI, 1.07-1.18]), diacyl-PC C40:6 (HR, 1.10 [95% CI, 1.04-1.15]), acyl-alkyl-PC C38:6 (HR, 1.11 [95% CI, 1.05-1.16]), diacyl-PC C38:6 (HR, 1.09 [95% CI, 1.04-1.14]) and diacyl-PC C38:5 (HR, 1.10 [95% CI, 1.05-1.16]))—with risk of incident coronary heart disease. These had comparable prognosticative values as individual classic risk factors.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries